Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer’s Blood Test
The test uses five biomarkers and proprietary technology to detect amyloid brain plaques in patients with cognitive symptoms.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
